Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Company News

FDA accepts Zegerid capsules NDA

June 29, 2005 1:03 AM UTC

FDA accepted for filing an NDA from Santarus (SNTS) for 20 and 40 mg Zegerid omeprazole capsules to treat the symptoms of gastroesophageal reflux disease (GERD), erosive esophagitis, duodenal ulcers a...